HKSE · 1177.HK
Sino Biopharmaceutical Limited
HK$4.82-HK$0.03 (-0.62%)
Sino Biopharmaceutical Limited’s quoted price sits in the lower half of its reported 52-week range, 35.56% below the high.
Loading market information…
OTC · CORBF · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 07:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Global Cord Blood Corporation’s quoted price sits in the lower half of its reported 52-week range, 45.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Global Cord Blood Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive testing, processing, and long-term storage of cord blood samples for its individual clients. Additionally, it undertakes the examination, preparation, and storage of donated cord blood units, facilitating their use for matching purposes. As of March 31, 2022, the corporation oversaw the management of three distinct cord blood banks, located in Beijing municipality, Guangdong province, and Zhejiang province. The entity previously operated as China Cord Blood Corporation, adopting its current name in March 2018, and functions as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:06 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
THE ANALYST VIEW
3 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$4.82-HK$0.03 (-0.62%)
Sino Biopharmaceutical Limited’s quoted price sits in the lower half of its reported 52-week range, 35.56% below the high.
HK$35.02-HK$2.68 (-7.11%)
Genscript Biotech Corporation’s quoted price sits in the upper half of its reported 52-week range, 29.2% below the high.
HK$2.83+HK$0.07 (+2.54%)
Alibaba Health Information Technology Limited’s quoted price sits in the lower half of its reported 52-week range, 64.29% below the high.
HK$38.70+HK$1.40 (+3.75%)
Fameglow Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 15.28% below the high.
HK$4.64+HK$0.14 (+3.11%)
China Resources Pharmaceutical Group Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.02% below the high.
$5.18-$0.01 (-0.19%)
Cryo-Cell International, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.05% below the high.
$31.00$0.00 (0.0%)
Bioqual, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.5% below the high.
$0.51$0.00 (0.0%)
Longduoduo Company Limited’s quoted price sits in the lower half of its reported 52-week range, 45.4% below the high.
